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Abstract 
Purpose: To evaluate the suitability of 99mTc-DTPA as a radiotracer in Persian cat's renal scintigraphy.  
Methods:  twelve adult healthy Persian cats were selected. For scintigraphy, the animals were 
anesthetized and 99mTC-DTPA was injected via the femoral vein as a bolus at a dose of 1.5 mCi. 
Immediately after intravenous injection of radiotracer, scintigraphic operation was conducted on the 
renal organ.  dministration of the radioisotope and accumulation of radioisotope in the tissues was 
monitored by specific imaging theemanating   
Results:  Distinct scintigraphic scans were obtained using 99mTC-DTPA. Visual comparison of the scans 
indicates that there was no significant difference in the accumulation of radiotracer.  In dynamic scans, 
symmetric and concurrent distribution of 99mTc-DTPA in the kidney was observed.   
Conclusion: The results show that the radiopharmaceutical 99mTc-DTPA is suitable for use in Persian 
cat's renal scintigraphy, and this makes it potentially useful in research and clinical practice.  
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Renal scintigraphy, also known as renal 
scanning, refers to several examinations using 
radioisotopes that evaluate the function and 
anatomy of the kidneys. Renal scintigraphy is 
one of many imaging methods used to evaluate 
the kidneys. Different types of renal scans are 
used to examine different aspects of the kidneys, 
however; these procedures involve the injection 
of radioactive substance that emits a tiny amount 
of radioactivity. The radiotracer accumulates 
differently in kinds of tissue and it can help 
physicians determine diagnosis.  
 
Renal scintigraphy can also be used to evaluate 
pathology of the kidney [1,2]. In this technique, a 
radioactive substance such as technetium-99m is 
mixed with special chelating agents. Technetium-
99m is a metastable nuclear isomer of 
technetium-99, symbolized as 99mTc, making it 
the most commonly used medical radioisotope. 
Technetium-99m when used as a radioactive 
tracer can be detected in the body by medical 
equipment (gamma camera) [3,4]. 
 
Various intermediate chelating agents labeled 
with technetium-99m are used for renal 
scintigraphy, the most commonly used agent 
being 99mTc-DTPA (Technetium-99m diethylene 
triamine pentacaetic acid). Also other agents as 
99mTc-labelled by MAG3 (mercapto acetyl 
triglycine), EC (ethyl cysteine), 131-Iodine 
labelled OIH (ortho iodo hippurate) can be used 
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[2,3]. After injection of radiotracer into the venous 
system, this compound is excreted by the 
kidneys and its progress through the renal 
system can be tracked with a gamma camera. 
DTPA is a kind of substance called a chelating 
agent. Chelating agents work by binding and 
holding on to radioactive materials or poisons 
that get into the body [2-4]. 
 
This study was aimed to determine the safety 
and suitability of 99mTc-DTPA for use in the 




Instruments and materials 
 
A double-detector ADAC Gama camera (Vertex 
model, Philips Inc.) and Capintec (CRC-5 model, 
Capintec, USA) dose calibrator machine were 
used. These apparatus were calibrated and 
specially designed software was used. DTPA kit 
(Kavoshyar, Iran) was obtained from Iran Nuclear 
Research Center. 99mTechnetium milked from 
molybdenum-technetium generator was prepared 
and confirmed by the Atomic Energy 




Twelve adult apparently healthy Persian cats 
were selected. Blood examinations such as 
Creatinine, Bun, CBC and clinical examinations 
were done for assurance of kidneys normality. 
Animals were housed in standard polypropylene 
cages at a temperature of 24 ± 3 °C, with free 
access to food and water. Procedures were 
carried out under the Ethical Committee 
guideline as "Principles of Laboratory Animal 
Care" (accordance with National Institutes of 
Health Publication No. 85-23, 1985) in Faculty of 
Veterinary Medicine, Tabriz Branch, Islamic Azad 




99mTc was milked from molybdenum-technetium 
generator and then added to diethylene triamine 
pentacaetic acid (DTPA) kit. After mixing the kit 
containing 99mTc–DTPA, 1.5 mCi from this 
material was measured by dose calibrator 
machine in an insulin syringe. For scintigraphy, 
animals were anesthetized and positioned on 
their backs. Scintillator of machine was set under 
the table near the kidneys. Before injection of the 
radiopharmaceutical agent, the test scintigraphic 
studies from animal and environment were done 
[2,3]. 
 
Thereafter, 99mTC-DTPA was injected into the 
femoral vein as bolus at a dose of 1.5 mCi. 
Immediately after rapid intravenous injection of 
radioactive agent, imaging was commenced. 
Secondary activity of the syringe after injection 
was measured by a dose calibrating machine. 
During the action, effort was careful made to 
ensure that the scanning process was not 
disrupted [1,3]. 
 
Animals were anesthetized with ketamine (10 
mg/kg, Alfasan, Woerden, Holland) as main drug 
and acepromazine (0.05 mg/kg, Alfasan, 
Woerden, Holland) as pre-anesthetic drug [7]. 
For better imaging, the animal’s injection area 
was covered with a lead guard. Immediately after 
injection, dynamic scanning was commenced. 
The computer program was set until images of 
angiophase at 1 min and other images were 
scanned in subsequent periods. Total duration of 
a cat scan was 30 min in renal nuclear imaging. 





Suitable representative scintigraphic scans were 
obtained by 99mTc-DTPA radiotracer and the 
images show the special distribution of the 
radiopharmaceutical agents. In visual 
comparison of scans, no significant difference in 
accumulation of radiotracer was observed.  In 
dynamic scans, symmetric and concurrent 
passage of 99mTc-DTPA from kidneys were seen. 
 
Figure 1 shows accumulation of 99mTC-DTPA in 
Persian cat's body. Figure 2 shows a sample of 
captured dynamic scans in different passing time 
of 99mTC-DTPA. The symmetric accumulation of 
radiotracer in the right and the left kidneys was 




Figure 1: Accumulation of 99m TC-DTPA in a Persian 
cat body 
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Renal scintigraphic imaging is very important in 
nuclear medicine. Renal disorders associated 
with the excretion of the kidneys, renal tubular 
failures and failures associated with the renal 
perfusion can be detected by scintigraphy. With 
this technique, the structural composition of the 
kidney and the physiological functions of the 
kidneys can be revealed. Kidneys are one of the 
very important body organs, for example, they 
excrete toxins and maintain body water. Most 
severe diseases of the kidney can be detected 
by this technique [1,2,9,10]. 
  
Scintigraphic images show the distribution of 
radiopharmaceutical agents such as 99mTC-
DTPA. Complications such as non-symmetric 
forms of kidneys, delayed absorption of 
radioactive material in the pelvis and uniform 
parenchymal may be important in diagnosis. 
Renal scintigraphy which uses 
radiopharmaceutical agent cannot attach to the 
protein and are not secreted or absorbed by the 
tubules. 99mTC–DTPA possesses the above 
mentioned properties, and can be tracked by 
gamma cameras in the stage of accumulating a 
sufficient number of gamma ray photons [3,11].   
 
It is possible to detect size, shape and position of 
the kidneys by radionuclide imaging with 99mTC-
DTPA. Scintigraphy has been proposed and 
used in evaluating the functional and 
physiological activities of kidneys [3,8]. 
Scintigraphy is used in animals especially in cats 
[8,12-15]. Renal scintigraphy is carried out in 
cats for many purposes. Our results are 
accordance with previous studies on renal 
scintigraphy in cat [8,15]. 99mTc-DTPA has been 
used in kidney scintigraphy [3,11]. In many 
studies, 99mTc-DTPA was used in cat diuretic 
renal scintigraphy in normal cats and those with 
nephroureterolithiasis and the results were found 
to be similar [8,15]. 
 
In the present study, radiotracer used is the 
same as that used in some studies [8-10]. The 
reports of side effects when this 
radiopharmaceutical was employed in some 
studies, such as kidney failure, allergic reactions 
and fatal side effects, were not observed in the 
present study.  
 
In this study, the radioactive count of the right 
kidney can be compared with that of the left 
kidney. Renal scintigraphy revealed the 
anatomical structure and physiological functions 
of the kidneys as reported previously [8]. With 
the accumulation of 99mTC-DTPA in Persian cats 
body in the scanned images, it seems that 
scintigraphy can identify certain diseases of the 
kidney, thus providing supplementary information 
for accurate diagnosis [2,13,15].  
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The investigation revealed that scintigraphy of 
Persian cat kidneys with 99mTC-DTPA has many 
similarities with human kidney scintigraphy [1-3]. 
Computer programs such as those used for 
scanning and collecting images, as well as for 
drawing ROIs can also applied to Persian cat 
without any problems. Evaluation of the Persian 
cat kidney scans revealed that detection of the 
radioactive agents was achievable using the 
computer programs of the gamma cameras. 
Illustration of the cat’s kidney ROIs was 
achievable by computer programs, and 
application of this technique in Persian cats was 
achieved just like for human kidney [1,3,14].  
 
Computer configurations for execution and time 
steps of scintigraphy operations in Persian cats 
are similar to those done in human. Scintigraphy 
is considered a useful method in diagnostic 
imaging and veterinary science. This study 
shows also that animals like cat can be used in 
medical research and veterinary medicine as a 
specific animal model used in nuclear medicine 




99mTc-DTPA radiotracer is suitable for use in 
cat's renal scintigraphy, and is thus potentially 
useful in research and clinical practice. Side 
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